In the SURMOUNT-2 study, which involved 938 adults with obesity or overweight and T2D, tirzepatide showed significant weight loss effects of 13.4% and 15.7% for the 10 and 15 mg doses, respectively, with over 80% of participants experiencing at least a 5% weight loss [92]
While BPC-157 appears to have more specific affinity for gastrointestinal healing, TB-500 (a synthetic version of Thymosin Beta-4) is studied more in the context of systemic recovery and muscle repair
For patients presenting with neurological symptoms, integrating the Neural Zoomer Plus may help identify antibodies to neural antigens, offering insight into potential autoimmune or inflammatory processes impacting the brain
BPC-157
Nevertheless, subsequent phase II trials for the combination of lapatinib and pazopanib in HER2-positive breast cancer failed to show survival advantage compared to lapatinib alone
Research-only product page GHK-Cu (100mg) | Research Use Only Transparent product information for laboratory research procurement
